A prospective study on the circulation and central nervous system after primary central nervous system B cell lymphoma treatment with rituximab.
2019
e13518Background: The use of
rituximab(RTX)for the treatment of
primary central nervous system lymphoma(PCNSL) is controversial, and whether the RTX permeability of the
blood-brain barriercan be i...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI